Biden Admin Proposes New Rules That Would Make It Harder For Americans To Get Certain Medications

Daily Wire NewsFebruary 24, 2023

President Joe Biden’s administration American would be unable to obtain certain medications if there are more restrictions.

The DEA proposal would make it more difficult for Americans to obtain Adderall or opioid painkillers if they are trying to access them through telehealth services. Telehealth services have significantly increased during the pandemic, leading to shortages in some medications.

Because of the influx in prescriptions for patients, the DEA began to crack down on telehealth services that allow people to get drugs first-time.

The proposed rules allow doctors to “remotely prescribe a 30-day supply of some drugs, including buprenorphine—used to treat opioid-use disorder—as well as ketamine and testosterone,” The Wall Street Journal reported. “Further prescriptions would require at least one in-person visit. Other drugs, including Adderall, Ritalin and OxyContin, would require patients to meet in-person with prescribers first or be referred from a doctor they met in person.”

CLICK HERE TO GET THE DAILY WIRE APP

According to the DEAThe new rules will not have any effect on:

Telemedicine consultations that do not involve the prescribing of controlled medications.Telemedicine consultations by a medical practitioner that has previously conducted an in-person medical examination of a patient.Telemedicine consultations and prescriptions by a medical practitioner to whom a patient has been referred, as long as the referring medical practitioner has previously conducted an in-person medical examination of the patient.

“DEA is committed to ensuring that all Americans can access needed medications,” said DEA Administrator Anne Milgram. “The permanent expansion of telemedicine flexibilities would continue greater access to care for patients across the country, while ensuring the safety of patients. DEA is committed to the expansion of telemedicine with guardrails that prevent the online overprescribing of controlled medications that can cause harm.”